semaglutide approval mash The FDA has granted accelerated for Wegovy (semaglutide 2.4 mg) to treat adults with noncirrhotic and moderate to advanced liver fibrosis, marking the first GLP-1 therapy approved for MASH, based Semaglutide, a GLP-1R agonist, is
Pay in 4 interest-free payments of $6.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25

























